Risk Factors for Postpartum Haemorrhage in Women with Histologically Verified Placenta Accreta Spectrum Disorders: a Retrospective Single-centre Cross-sectional Study

Overview

Journal BMC Pregnancy Childbirth

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2023 Nov 11

PMID 37951863

Authors

Naghmeh Ghaem Maghami

Fabrice Helfenstein

Gwendolin Manegold-Brauer

Gabriela Amstad

Affiliations

Soon will be listed here.

Abstract

Background: Placenta accreta spectrum (PAS) disorders have been reported with an increasing frequency of up to 3%. The increase in the incidence can be explained by the rising rate of Caesarean section (CS), assisted reproductive technology (ART) and previous uterine surgeries. PAS disorders are usually associated with postpartum haemorrhage (PPH). In our study, we investigated the risk factors for increased blood loss in women with histologically verified PAS disorders independent of delivery mode.

Methods: In a retrospective single-centre cross-sectional study, 2,223 pregnant women with histologically verified PAS disorders were included. Risk factors for PPH in women with PAS disorders were examined and compared between women with PPH (study group; n = 879) and women with normal blood loss (control group; n = 1150), independent of delivery mode. PAS disorders were diagnosed histologically from the following specimens: placenta, placental-bed specimens, uterine curettage, uterine resection and/or total/partial hysterectomy. Medical data were extracted from clinical records of pregnant women with PAS disorders delivering at the University Hospital Basel between 1986 and 2019. The placenta data of women with PAS disorders were obtained and identified through a search from the database of the Department of Pathology, University Hospital Basel.

Results: Between 1986 and 2019, there were 64,472 deliveries at the University Hospital Basel. PAS disorders were histologically verified in 2,223 women (2,223/64,472), and the prevalence of PAS disorders was 3.45%. A total of 879 women with PAS disorders showed PPH, independent of delivery mode (43.3%). Due to missing data for 194 women, the final analysis was conducted with the remaining 2,029 women. Placenta praevia (O.R. = 6.087; 95% CI, 3.813 to 9.778), previous endometritis (O.R. = 3.011; 95% CI, 1.060 to 9.018), previous manual placenta removal (O.R. = 2.530; 95% CI, 1.700 to 3.796), ART (O.R. = 2.169; 95% CI, 1.593 to 2.960) and vaginal operative birth (O.R. = 1.715; 95% CI, 1.225-2.428) can be considered important risk factors, and previous CS (O.R. = 1.408; 95% CI, 1.016 to 1.950) can be considered a moderate potential risk factor of PPH in women with PAS disorders.

Conclusions: Placenta praevia, previous endometritis, previous placenta removal, ART and vaginal operative birth can be considered important risk factors of PPH in women with PAS disorders.

Study Registration: The study was registered under http://www.

Clinicaltrials: gov (NCT05542043) on 15 September 2022.

Citing Articles

Chitosan-covered tamponade for the treatment of postpartum hemorrhage: a registry-based cohort study assessing outcomes and risk factors for treatment failure.

Leichtle C, Aigner A, Biele C, Hermann P, Dangli T, Waldner C BMC Pregnancy Childbirth. 2025; 25(1):120.

PMID: 39910452 PMC: 11796112. DOI: 10.1186/s12884-025-07236-5.

Unexpected placenta accreta spectrum in an unscarred uterus causing catastrophic post-partum hemorrhage: a case report and review of the literature.

Garg P, Semwal S, Bansal R BMC Pregnancy Childbirth. 2025; 25(1):14.

PMID: 39780055 PMC: 11707907. DOI: 10.1186/s12884-025-07140-y.

The Association and diagnostic value between Maternal Serum Placental Markers and Placenta Previa.

Ma P, Hu T, Chen Y Eur J Obstet Gynecol Reprod Biol X. 2024; 24:100346.

PMID: 39483207 PMC: 11525459. DOI: 10.1016/j.eurox.2024.100346.

References

Wright J, Pri-Paz S, Herzog T, Shah M, Bonanno C, Lewin S . Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol. 2011; 205(1):38.e1-6. DOI: 10.1016/j.ajog.2011.01.040. View

Sheiner E, Sarid L, Levy A, Seidman D, Hallak M . Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neonatal Med. 2005; 18(3):149-54. DOI: 10.1080/14767050500170088. View

Andrikopoulou M, DAlton M . Postpartum hemorrhage: early identification challenges. Semin Perinatol. 2018; 43(1):11-17. DOI: 10.1053/j.semperi.2018.11.003. View

Abdul-Kadir R, McLintock C, Ducloy A, El-Refaey H, England A, Federici A . Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion. 2014; 54(7):1756-68. DOI: 10.1111/trf.12550. View

Fitzpatrick K, Sellers S, Spark P, Kurinczuk J, Brocklehurst P, Knight M . Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2013; 7(12):e52893. PMC: 3531337. DOI: 10.1371/journal.pone.0052893. View

Neary C, Naheed S, McLernon D, Black M . Predicting risk of postpartum haemorrhage: a systematic review. BJOG. 2020; 128(1):46-53. DOI: 10.1111/1471-0528.16379. View

Higgins N, Patel S, Toledo P . Postpartum hemorrhage revisited: new challenges and solutions. Curr Opin Anaesthesiol. 2019; 32(3):278-284. DOI: 10.1097/ACO.0000000000000717. View

Oyelese Y, Ananth C . Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol. 2010; 53(1):147-56. DOI: 10.1097/GRF.0b013e3181cc406d. View

. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122(5):1122-1131. DOI: 10.1097/01.AOG.0000437382.03963.88. View

10.

Jauniaux E, Gronbeck L, Bunce C, Langhoff-Roos J, Collins S . Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ Open. 2019; 9(11):e031193. PMC: 6858111. DOI: 10.1136/bmjopen-2019-031193. View

11.

Aalipour S, Salmanian B, Fox K, Clark S, Shamshirsaz A, Asl N . Placenta Accreta Spectrum: Correlation between FIGO Clinical Classification and Histopathologic Findings. Am J Perinatol. 2021; 40(2):149-154. DOI: 10.1055/s-0041-1728834. View

12.

Schlembach D, Helmer H, Henrich W, von Heymann C, Kainer F, Korte W . Peripartum Haemorrhage, Diagnosis and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/063, March 2016). Geburtshilfe Frauenheilkd. 2018; 78(4):382-399. PMC: 5925693. DOI: 10.1055/a-0582-0122. View

13.

Sosa C, Althabe F, Belizan J, Buekens P . Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population. Obstet Gynecol. 2009; 113(6):1313-1319. PMC: 2730945. DOI: 10.1097/AOG.0b013e3181a66b05. View

14.

Ali H, Chandraharan E . Etiopathogenesis and risk factors for placental accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2020; 72:4-12. DOI: 10.1016/j.bpobgyn.2020.07.006. View

15.

Hecht J, Baergen R, Ernst L, Katzman P, Jacques S, Jauniaux E . Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol. 2020; 33(12):2382-2396. DOI: 10.1038/s41379-020-0569-1. View

16.

Wortman A, Alexander J . Placenta accreta, increta, and percreta. Obstet Gynecol Clin North Am. 2013; 40(1):137-54. DOI: 10.1016/j.ogc.2012.12.002. View

17.

Nyflot L, Sandven I, Stray-Pedersen B, Pettersen S, Al-Zirqi I, Rosenberg M . Risk factors for severe postpartum hemorrhage: a case-control study. BMC Pregnancy Childbirth. 2017; 17(1):17. PMC: 5223545. DOI: 10.1186/s12884-016-1217-0. View

18.

Karami M, Jenabi E, Fereidooni B . The association of placenta previa and assisted reproductive techniques: a meta-analysis. J Matern Fetal Neonatal Med. 2017; 31(14):1940-1947. DOI: 10.1080/14767058.2017.1332035. View

19.

Metzger B, Gabbe S, Persson B, Buchanan T, Catalano P, Damm P . International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33(3):676-82. PMC: 2827530. DOI: 10.2337/dc09-1848. View

20.

Thurn L, Lindqvist P, Jakobsson M, Colmorn L, Klungsoyr K, Bjarnadottir R . Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG. 2015; 123(8):1348-55. DOI: 10.1111/1471-0528.13547. View